Cannlabs Valuation
| CANL Stock | USD 0.0001 0.00 0.00% |
Cannlabs seems to be overvalued based on Macroaxis valuation methodology. Our model approximates the value of Cannlabs from analyzing the firm fundamentals such as Return On Asset of -3.62, shares outstanding of 62.63 M, and Operating Margin of (2.50) % as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Cannlabs' price fluctuation is very steady at this time. Calculation of the real value of Cannlabs is based on 3 months time horizon. Increasing Cannlabs' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Cannlabs pink sheet is determined by what a typical buyer is willing to pay for full or partial control of Cannlabs. Since Cannlabs is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Cannlabs Pink Sheet. However, Cannlabs' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.0E-4 | Real 8.4E-5 | Hype 1.0E-4 |
The intrinsic value of Cannlabs' stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Cannlabs' stock price.
Estimating the potential upside or downside of Cannlabs helps investors to forecast how Cannlabs pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Cannlabs more accurately as focusing exclusively on Cannlabs' fundamentals will not take into account other important factors: Cannlabs Total Value Analysis
Cannlabs is currently estimated to have valuation of 14.91 M with market capitalization of 14.76 M, debt of 0, and cash on hands of 17.59 K. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Cannlabs fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
14.91 M | 14.76 M | 0 | 17.59 K |
Cannlabs Investor Information
The company recorded a loss per share of 0.03. Cannlabs had not issued any dividends in recent years. The entity had 7:1 split on the 12th of June 2014. Based on the key indicators related to Cannlabs' liquidity, profitability, solvency, and operating efficiency, Cannlabs is not in a good financial situation at this time. It has a very high probability of going through financial hardship in April.Cannlabs Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Cannlabs has an asset utilization ratio of 103.58 percent. This suggests that the Company is making $1.04 for each dollar of assets. An increasing asset utilization means that Cannlabs is more efficient with each dollar of assets it utilizes for everyday operations.Cannlabs Profitability Analysis
The company reported the previous year's revenue of 1.36 M. Net Loss for the year was (1.58 M) with profit before overhead, payroll, taxes, and interest of 478.11 K.About Cannlabs Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Cannlabs. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Cannlabs based exclusively on its fundamental and basic technical indicators. By analyzing Cannlabs's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Cannlabs's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Cannlabs. We calculate exposure to Cannlabs's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Cannlabs's related companies.CannLabs, Inc. provides cannabis testing laboratory services in the United States. The company also offers dataanalytics and consulting, as well as education services. Cannlabs operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 37 people.
8 Steps to conduct Cannlabs' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Cannlabs' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Cannlabs' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Cannlabs' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Cannlabs' revenue streams: Identify Cannlabs' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Cannlabs' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Cannlabs' growth potential: Evaluate Cannlabs' management, business model, and growth potential.
- Determine Cannlabs' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Cannlabs' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Cannlabs Growth Indicators
Investing in growth stocks can be very risky. If the company such as Cannlabs does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Retained Earnings | -1.6 M |
Other Information on Investing in Cannlabs Pink Sheet
Cannlabs financial ratios help investors to determine whether Cannlabs Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cannlabs with respect to the benefits of owning Cannlabs security.